Capillary Technologies India Performance
- Today's Low
- ₹491
- Today's High
- ₹506
- 52 Week Low
- ₹464
- 52 Week High
- ₹799
- Open Price₹496
- Previous Close₹496
- Volume246,923
- 50 DMA₹521.51
- 100 DMA₹552.98
- 200 DMA-
Capillary Technologies India Chart
Investment Returns
- Over 1 Month -4.59%
- Over 3 Month -2.7%
- Over 6 Month -26.95%
- Over 1 Year -14.17%
Smart Investing Starts Here Start SIP with Capillary Technologies India for Steady Growth!
Capillary Technologies India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 75.1
- PEG Ratio
- -
- Market Cap Cr
- 3,936
- P/B Ratio
- 3.8
- Average True Range
- 18.14
- EPS
- 3.73
- Dividend Yield
- 0
- MACD Signal
- -8.4
- RSI
- 38.18
- MFI
- 90.4
Latest Stock News Updates
Capillary Technologies India's stock has fallen 35% from its peak due to AI threats and a muted December quarter. The company, which offers a SaaS platform for customer engagement, faces potential revenue and profit contraction. Despite management's optimism about AI's role in analytics and campaign management, investors are concerned about its impact on the business model.
- Economic Times
- 3 months 2 weeks ago
The acquisition gives Capillary access to SessionM's annualised recurring revenue of approximately $35 million and a client roster of over 40 enterprise customers, including five Fortune 500 companies
- Business Line
- 3 months 3 weeks ago
IT Software Products company Capillary Technologies India announced Q3FY26 results Operating Revenue of Rs 1,840.4 million. vs. Rs 1,590.0 million. (+16% YoY) Adjusted EBITDA of Rs 301.4 million. vs. Rs 242.8 million. (+24% YoY) PAT of Rs 79.9 million. vs. Rs 114.2 million. (-30% YoY), lower on account of higher depreciation and amortization (Rs 62.4 million.) related to the Kognitiv acquisition and one time expenses (Rs 35.9 million.) related to IPO expenses and Direct Labour Code impact. Aneesh Reddy Boddu, Founder, MD & CEO, said, “We delivered a healthy quarter, led by NRR expansion, continued addition of large enterprise customers across geographies and strong performance of our most recent acquisition. We had some successful go-lives in the healthcare vertical increasing our current subscriber member base by 50% effective Jan 1, 2026. We are unlocking AI-led productivity improvements across the business and are building AI-powered migration capabilities that are designed to significantly optimise migration efforts. We plan to accelerate customer migration to leverage the benefits from our core platform. As we approach the end of this fiscal year, with our continued focus on sustaining disciplined growth through our levers of organic expansion, we are also encouraged to continue our strategic R&D;, GTM and inorganic acquisition investments that will help us deliver sustained, profitable growth.” Result PDF
- Trendlyne
- 4 months 1 week ago
Capillary Technologies India Financials
Capillary Technologies India Technicals
EMA & SMA
- Bearish Moving Average 13
- Bullish Moving Average 0
- 20 Day
- ₹507.10
- 50 Day
- ₹521.50
- 100 Day
- ₹553.00
- 200 Day
- -
Resistance and Support
- R3 518.83
- R2 512.42
- R1 503.83
- S1 488.83
- S2 482.42
- S3 473.83
Capillary Technologies India Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-06 | Audited Results | |
| 2026-02-06 | Quarterly Results |
About Capillary Technologies India
- NSE Symbol
- CAPILLARY
- BSE Symbol
- 544614
- Managing Director & CEO
- Mr. Aneesh Reddy Boddu
- ISIN
- INE0ILV01024
Similar Stocks to Capillary Technologies India
Popular Stocks
Capillary Technologies India FAQs
Capillary Technologies India share price is ₹495 As on 20 June, 2026 | 01:49
The Market Cap of Capillary Technologies India is ₹3935.9 Cr As on 20 June, 2026 | 01:49
The P/E ratio of Capillary Technologies India is 75.1 As on 20 June, 2026 | 01:49
The PB ratio of Capillary Technologies India is 3.8 As on 20 June, 2026 | 01:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.